| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.3 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |